SEIDIZADEH, OMID
SEIDIZADEH, OMID
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD with VWF A2 Domain Mutations
2025 O. Seidizadeh, L. Mollica, D. Giana, L. Baronciani, P. Colpani, L. Sicuro, A. Cairo, F. Peyvandi
VON WILLEBRAND DISEASE: NEW INSIGHTS INTO THE EPIDEMIOLOGY, PATHOPHYSIOLOGY AND GENOTYPE/PHENOTYPE CORRELATION
2025 O. Seidizadeh
Global prevalence of platelet-type von Willebrand disease
2025 O. Seidizadeh, A. Cairo, M. Othman, F. Peyvandi
Clarifying the role of p.Gln723Lys in hTTP prevalence
2025 O. Seidizadeh, A. Cairo, I. Mancini, J.N. George, F. Peyvandi
Challenges and considerations of genetic testing in von Willebrand disease
2025 O. Seidizadeh, L. Baronciani, F. Peyvandi
The genetic spectrum of rare bleeding disorders
2025 S. Mohsenian, O. Seidizadeh, A. Cairo, R. Palla, M. Menegatti, F. Peyvandi
Effect of the Polymorphic Variant p.D1472H on the Platelet‐Dependent VWF Activity Assays
2025 O. Seidizadeh, L. Pati, L. Baronciani, P. Colpani, G. Cozzi, M.T. Pagliari, C. Novembrino, A. Cairo, E. Pappalardo, F. Peyvandi
Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease
2024 O. Seidizadeh, L. Baronciani, P. Colpani, G. Cozzi, A. Ciavarella, S.M. Siboni, F. Peyvandi
Exploring nonreplacement therapies’ impact on hemophilia and other rare bleeding disorders
2024 F. Peyvandi, O. Seidizadeh, S. Mohsenian, I. Garagiola
Application of genetic testing for the diagnosis of von Willebrand disease
2024 O. Seidizadeh, L. Baronciani, D. Lillicrap, F. Peyvandi
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
2024 O. Seidizadeh, L. Mollica, S. Zambarbieri, L. Baronciani, A. Cairo, P. Colpani, G. Cozzi, M.T. Pagliari, A. Ciavarella, S.M. Siboni, F. Peyvandi
Global Prevalence of Hereditary Thrombotic Thrombocytopenic Purpura Determined by Genetic Analysis
2024 O. Seidizadeh, A. Cairo, I. Mancini, J.N. George, F. Peyvandi
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF
2024 O. Seidizadeh, A. Ciavarella, L. Baronciani, F. Boggio, F. Ballardini, G. Cozzi, P. Colpani, M.T. Pagliari, C. Novembrino, S.M. Siboni, F. Peyvandi
von Willebrand disease
2024 O. Seidizadeh, J.C.J. Eikenboom, C.V. Denis, V.H. Flood, P. James, P.J. Lenting, L. Baronciani, J.S. O'Donnell, D. Lillicrap, F. Peyvandi
Genetic determinants of enhanced von Willebrand factor clearance from plasma
2023 O. Seidizadeh, L. Baronciani, M.T. Pagliari, G. Cozzi, P. Colpani, A. Cairo, S.M. Siboni, E. Biguzzi, F. Peyvandi
Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP®
2023 O. Seidizadeh, F. Peyvandi
Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases
2023 O. Seidizadeh, A. Cairo, L. Baronciani, L. Valenti, F. Peyvandi
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies
2023 S. Mohsenian, O. Seidizadeh, R. Palla, M. Jazebi, A. Azarkeivan, S. Moazezi, M.R. Baghaipour, M. Menegatti, F. Peyvandi
Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2
2022 O. Seidizadeh, L. Baronciani, M.T. Pagliari, G. Cozzi, P. Colpani, A. Cairo, S.M. Siboni, E. Biguzzi, F. Peyvandi
Von Willebrand disease type 2N: An update
2021 O. Seidizadeh, F. Peyvandi, P.M. Mannucci